Clinical Observation of Treatment of Hypertension and Coronary Heart Disease with Amlodipine Atorvastatin Calcium Tablet

Fu Zhong Yang; Yi Jing

Article Contents

Article Navigation > Journal of Kunming Medical University > 2017 > 38(10): 117-119

Fu Zhong Yang , Yi Jing . Clinical Observation of Treatment of Hypertension and Coronary Heart Disease with Amlodipine Atorvastatin Calcium Tablet[J]. Journal of Kunming Medical University, 2017, 38(10): 117-119.

Citation:

Fu Zhong Yang , Yi Jing . Clinical Observation of Treatment of Hypertension and Coronary Heart Disease with Amlodipine Atorvastatin Calcium Tablet[J]. Journal of Kunming Medical University, 2017, 38(10): 117-119.

Citation:

PDF( 146 KB)

Clinical Observation of Treatment of Hypertension and Coronary Heart Disease with Amlodipine Atorvastatin Calcium Tablet

Fu Zhong Yang ¹,
Yi Jing ²

Funds:

基金：武警部队卫生部自然科学基金资助项目 (WJWSB2012-10);

Received Date: 2017-04-20

Abstract

Abstract

Objective To discuss the treatment effect of amlodipine atorvastatin calcium tablets on hypertensive patients with coronary heart disease. Methods Sixty patients with hypertension combined coronary heart disease were randomly divided into two groups. The patients received the amlodipine atorvastatin calcium treatment were as the experimental group, the patients received nifedipine zyban treatment were as the control group, then we compared the effect of two groups.Results The total efficiency of the control group was lower than the experimental group, and the difference was statistically significant (P < 0.05) .The adverse reactions in the experimental group were less than the control group, and the difference was not statistically significant (P > 0.05) .Conclusion Amlodipine atorvastatin calcium tablet is simple and effective in the treatment of patients with hypertension combined with coronary heart disease, and has great value in clinic.
- High blood pressure,
- Coronary heart disease,
- Amlodipine atorvastatin calcium tablet

FullText(HTML)

References(7)

References

[1]李莉, 徐志勇, 禹颖, 等.麝香保心丸联合氨氯地平阿托伐他汀钙治疗高血压合并冠心病的疗效观察[J].现代药物与临床, 2016, 31 (3) :302-305.
[2]尹秀芹.氨氯地平联合阿托伐他汀钙片治疗高血压合并冠心病的临床疗效观察[J].临床合理用药杂志, 2017, 10 (2) :26-27.
[3]郑鹏, 商帅.阿托伐他汀联合氨氯地平治疗高血压病合并冠心病的疗效观察[J].中国医院用药评价与分析, 2016, 16 (12) :1633-1634.
[4]黄润珍, 梁绮雯, 张国浩, 等.氨氯地平阿托伐他汀钙片治疗高血压病合并冠心病的疗效观察[J].中国医院用药评价与分析, 2016, 16 (7) :921-922, 923.
[5]王印伟, 董红艳, 刘芳, 等.氨氯地平阿托伐他汀钙片联合护理干预治疗高血压病合并冠心病的疗效观察[J].中国医院用药评价与分析, 2017, 17 (3) :349-350.
[6]	[6]SEVER P S, CHANG C L, PRESCOTT M F, et al.Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients observations from the snglo-dcandinavian vardiac outcomes trial (ASCOT) [J].European Heart Journal:The Journal of the European Society of Cardiology, 2012, 33 (23) :2970-2979.
[7]杨书文, 张晏, 付静, 等.氨氯地平阿托伐他汀钙片对高血压合并冠心病的临床疗效分析[J].现代生物医学进展, 2013, 13 (1) :116-118.

Relative Articles(20)

Relative Articles

[1]	Shuangshuang XU, Wei ZHAO, Lei JIANG, Huajiang LIU, Fang WANG, Zhisheng TAN, Likun ZHOU. Correlation Between TyG Index，MHR and Coronary Lesions，Myocardial Ischemia in Patients with Coronary Heart Disease，and the Value of Combined Detection. Journal of Kunming Medical University, 2024, 45(3): 65-71. doi: 10.12259/j.issn.2095-610X.S20240310
[2]	Wenqing MIAO, Yu WANG, Xiaoli ZHAO, Nini TIAN, Liying YOU. Analysis of Differential Gene Expression and Function in Peripheral Blood of Patients with Coronary Heart Disease and Acute Myocardial Infarction. Journal of Kunming Medical University, 2022, 43(6): 25-34. doi: 10.12259/j.issn.2095-610X.S20220614
[3]	Bin LIU, Xian-gang LI, Min ZHANG, Fang ZHOU, Ren-hua LIN, Jie YANG, Liang ZHANG, Xian-kun WANG, Ya-nan PAN. Main Influencing Factors of the Second Hospitalization of Patients with Coronary Heart Disease. Journal of Kunming Medical University, 2021, 42(6): 103-109. doi: 10.12259/j.issn.2095-610X.S20210618
[4]	Jing TANG, Jun-chao HUANG, Ya-fei HUANG, Ming-zhu GENG, Xiao-qin MAO, Jian-ping PU. Application of Lipoprotein-associated Phospholipase A2 in Coronary Heart Disease Patients Taking Statins. Journal of Kunming Medical University, 2021, 42(12): 6-10. doi: 10.12259/j.issn.2095-610X.S20211205
[5]	Dai Hai Long , Zhang Xing , Pan Yun , Feng Xiao Lan , Lu Xiang Ting , Guang Xue Feng , Yin Xiao Long . . Journal of Kunming Medical University, 2020, 41(04): 60-63.
[6]	Xu XU, Li-yong WU, Ming-li ZHOU, Guo-fu ZHU. Relationship between microRNA-146a and the Plaque Stability in Coronary Heart Disease Patients. Journal of Kunming Medical University, 2020, 41(11): 56-61. doi: 10.12259/j.issn.2095-610X.S20201119
[7]	Wang Ji Yan , Duan Yong . . Journal of Kunming Medical University, 2018, 39(12): 1-4.
[8]	Li Lin , Li Ji Yi , Wang De Zhao , Liu Wei . 武汉地区123例冠心病患者CYP2C19基因多态性分布. Journal of Kunming Medical University, 2017, 38(06): 60-63.
[9]	Xiao Yi . The Clinical Effect of CDSP Treatment for Coronary Heart Disease. Journal of Kunming Medical University,
[10]	Li Wen Hua , Wei Yun Hong , Ye Ji Yun . Effect of Probiotics on Blood Lipid Metabolism of Elderly Patients with Coronary Heart Disease. Journal of Kunming Medical University, 2016, 37(12): 82-84.
[11]	Dai Qing Yuan . . Journal of Kunming Medical University,
[12]	Feng Yong Hong . . Journal of Kunming Medical University,
[13]	Zhou Kai Hua . . Journal of Kunming Medical University,
[14]	Yang Ping . . Journal of Kunming Medical University,
[15]	Tan Xiao Bing . . Journal of Kunming Medical University,
[16]	Zhang Ti Ling . . Journal of Kunming Medical University,
[17]	Li Hong Dao . . Journal of Kunming Medical University,
[18]	Yang Zheng . . Journal of Kunming Medical University,
[19]	Yin Lin . . Journal of Kunming Medical University,
[20]	Lv Han Xian . Detection of Periodontopathogens in Subgingival Plaque of Patients with Coronary Heart Disease and Periodontitis. Journal of Kunming Medical University,